Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”

Código QR

Reply to “Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?”

Guardado en:

Detalles Bibliográficos
Autores principales:	David S. Fedson, Jeffrey R. Jacobson, Ole Martin Rordam, Steven M. Opal
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2016
Materias:	Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/1244e1007a4f440fad7329796af13c3f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Treating the Host Response to Ebola Virus Disease with Generic Statins and Angiotensin Receptor Blockers
por: David S. Fedson, et al.
Publicado: (2015)

Generic Statins and Angiotensin Receptor Blockers: Are They Really Useful in Ebola?
por: Viroj Wiwanitkit
Publicado: (2016)

Reply to Siniorakis et al., “COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure”
por: David S. Fedson, et al.
Publicado: (2020)

Hiding in Plain Sight: an Approach to Treating Patients with Severe COVID-19 Infection
por: David S. Fedson, et al.
Publicado: (2020)

Reply to “Statins may decrease the Fatality Rate of MERS Infection”
por: Allison L. Totura, et al.
Publicado: (2015)

Statins Suppress Ebola Virus Infectivity by Interfering with Glycoprotein Processing
por: Punya Shrivastava-Ranjan, et al.
Publicado: (2018)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang C, et al.
Publicado: (2021)

Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by <i>In Situ</i> Proximity Ligation
por: Eva Mittler, et al.
Publicado: (2021)

Angiotensin receptor blocker telmisartan suppresses renal gluconeogenesis during starvation
por: Tojo A, et al.
Publicado: (2015)

Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Marco Rossato, et al.
Publicado: (2020)

Chasing Ebola through the Endosomal Labyrinth
por: M. Javad Aman
Publicado: (2016)

Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: Anti-arrhythmic Drug for Arrhythmogenic Right Ventricular Cardiomyopathy
por: Bin Tu, et al.
Publicado: (2021)

Reply to “Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments”
por: Arturo Casadevall, et al.
Publicado: (2014)

Response to the Comment ‘Smoking and Angiotensin-converting Enzyme Inhibitor/Angiotensin Receptor Blocker Cessation to Limit Coronavirus Disease 2019
por: Maki Komiyama, et al.
Publicado: (2020)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Jin-Ying Fang, et al.
Publicado: (2020)

Organoprotecive effects of angiotensin II receptor blockers in patients with type 2 diabetes mellitus
por: Ivona Yanovna Yarek-Martynova, et al.
Publicado: (2010)

Improved Histoarchitectural Changes with Angiotensin Receptor Blockers in Early Testicular and Cauda Toxicity in Rats
por: Faddladdeen,Khadija Abduljalil, et al.
Publicado: (2019)

Reply to “The Underestimation of Global Microbial Diversity”
por: Rudolf Amann, et al.
Publicado: (2016)

Direct Visualization of Ebola Virus Fusion Triggering in the Endocytic Pathway
por: Jennifer S. Spence, et al.
Publicado: (2016)

Host-Primed Ebola Virus GP Exposes a Hydrophobic NPC1 Receptor-Binding Pocket, Revealing a Target for Broadly Neutralizing Antibodies
por: Zachary A. Bornholdt, et al.
Publicado: (2016)

Reply to “Understanding the Role of Fungi in Chronic Wounds”
por: Lindsay Kalan, et al.
Publicado: (2016)

Reply to “Precedence for the Structural Role of Flagella in Biofilms”
por: Regine Hengge
Publicado: (2013)

Reply to “Triclocarban and Health: the Jury Is Still Out”
por: Lauren Pischel, et al.
Publicado: (2016)

Evaluation of the Potential Impact of Ebola Virus Genomic Drift on the Efficacy of Sequence-Based Candidate Therapeutics
por: Jeffrey R. Kugelman, et al.
Publicado: (2015)

Reply to “Funding by Lottery: Political Problems and Research Opportunities”
por: Arturo Casadevall, et al.
Publicado: (2016)

Comprehensive Functional Analysis of N-Linked Glycans on Ebola Virus GP1
por: Nicholas J. Lennemann, et al.
Publicado: (2014)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Michael T. Osterholm, et al.
Publicado: (2015)

The impact of discontinuation of sacubitril–valsartan and shifting to angiotensin-converting enzyme inhibitor or angiotensin receptor blocker in patients with heart failure with reduced ejection fraction
por: Osama A. Amin, et al.
Publicado: (2021)

Reply to “‘Tolerance’ of Misused Terminology? Enforcing Standardized Phenotypic Definitions”
por: Jakob Haaber, et al.
Publicado: (2015)

Deep Sequencing Identifies Noncanonical Editing of Ebola and Marburg Virus RNAs in Infected Cells
por: Reed S. Shabman, et al.
Publicado: (2014)

COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure
por: Eftychios Siniorakis, et al.
Publicado: (2020)

Statins May Decrease the Fatality Rate of Middle East Respiratory Syndrome Infection
por: Shu Yuan
Publicado: (2015)

Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials.
por: Jia Yao, et al.
Publicado: (2021)

Reply to “Conclusive Evidence of Replication of a Plant Virus in Honeybees Is Lacking”
por: Ji Lian Li, et al.
Publicado: (2014)

Reply to “Improving Microbiology Research: the Problems Are Less Statistical and More Biological”
por: Arturo Casadevall, et al.
Publicado: (2016)

Reply to “Unrealistic Nonphysiological Amounts of Reagents and a Disregard for Published Literature”
por: Alistair J. P. Brown
Publicado: (2015)

Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials.
por: Shuang Li, et al.
Publicado: (2014)

ACE-inhibitor/angiotensin receptor blockers (ACE-I/ARBs) therapy in COVID-19 infected dialysis patients
por: Ahmed Daoud, et al.
Publicado: (2021)

Reply to “Misclassification of PfEH1 and PfEH2 as Epoxide Hydrolases”
por: Daniel E. Goldberg, et al.
Publicado: (2017)

Valuing Knowledge: a Reply to the Epistemological Perspective on the Value of Gain-of-Function Experiments
por: Nicholas Greig Evans
Publicado: (2014)